...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole.
【24h】

Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole.

机译:微晶纤维素是在药物纳米混悬液冷冻干燥过程中用作基质形成剂的蔗糖的有用替代品-以伊曲康唑为例的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Itraconazole nanosuspensions, stabilized with 10% TPGS (relative to the weight of itraconazole), were transformed into nanoparticulate powders by freeze-drying. The crystalline itraconazole nanoparticles showed peak broadening in the X-ray powder diffraction spectra and a lower melting point as inferred from differential scanning calorimetry. As it was found that freeze-drying compromised dissolution behavior, sucrose was added as a matrix, former (50,100 and 200%, relative to the weight of itraconazole). Higher amounts of sucrose unexpectedly resulted in a decrease in the dissolution rate. After thorough evaluation of the powders, it was found that whereas higher sucrose content showed a cryoprotective effect, agglomeration during the final phase of the subsequent drying step tended to increase with higher amounts of sucrose. Therefore, microcrystalline cellulose (MCC) was evaluated as an alternative matrix former. The inclusion of MCC resulted in fast dissolution that increased with increasing amounts of MCC [for powders containing 50%,100% and 200% MCC, (relative to the weight of itraconazole), the times required for 63.2% release were 10.5+/-0.7, 6.4+/-1.2 and 3.1+/-0.5min, respectively]. The dissolution profiles showed an initial phase of burst dissolution, followed by a phase of slower release. As the fraction showing burst dissolution increased with higher MCC content, the system holds promise to maintain the dissolution enhancing properties of nanoparticles in the dry form.
机译:用10%TPGS(相对于伊曲康唑的重量)稳定的伊曲康唑纳米悬浮液通过冷冻干燥转化为纳米微粒粉末。从差示扫描量热法推断,结晶的伊曲康唑纳米颗粒在X射线粉末衍射光谱中显示出峰展宽和较低的熔点。由于发现冷冻干燥损害了溶解行为,因此添加蔗糖作为基质,前者(相对于伊曲康唑的重量为50,100和200%)。较高的蔗糖量出乎意料地导致溶解速率降低。在对粉末进行彻底评估后,发现虽然较高的蔗糖含量显示出防冻效果,但在随后的干燥步骤的最后阶段,随着蔗糖含量的增加,结块趋于增加。因此,评估了微晶纤维素(MCC)作为替代的基质形成剂。包含MCC导致快速溶解,并随MCC量的增加而增加[对于含有50%,100%和200%MCC的粉末(相对于依他康唑的重量),释放63.2%所需的时间为10.5 +/-分别为0.7、6.4 +/- 1.2和3.1 +/- 0.5分钟]。溶出曲线显示爆发溶出的初始阶段,随后是缓慢释放的阶段。随着显示出爆发溶解的级分随着更高的MCC含量而增加,该系统有望维持干燥形式的纳米颗粒的溶解增强性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号